A marriage of formal methods and LLMs seeks to harness the strengths of both.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

AI agents lack independent agency but can still seek multistep, extrapolated goals when prompted. Even if some of those prompts include AI-written text (which may become more of an issue in the ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). General collateral financing (GCF) trades are a form of repurchase agreements ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...